EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study

Samuel E Christen iD, Laura Hermann, Elias Bekka iD, Celina Vonwyl, Felix Hammann iD, Vera van der Velpen iD, Chin B Eap iD, Neal L Benowitz iD, Manuel Haschke iD, Evangelia Liakoni iD

Nicotine and Tobacco Research · 2024

DOI: 10.1093/ntr/ntae074 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2024. Verfasst von Samuel E Christen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switz…. Hauptthemen laut MEDLINE: Cross-Over Studies, Nicotine, Electronic Nicotine Delivery Systems, Vaping. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Teaching and Research, Insel Gruppe AG, University Hospital Bern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Popular “pod-style” e-cigarettes commonly use nicotine salt-based e-liquids that cause less irritation when inhaled and can deliver higher nicotine concentrations than free-base nicotine. This study investigated the pharmacokinetic and pharmacodynamic effects of different nicotine formulations (salt vs. free-base) and concentrations that might influence systemic nicotine absorption and appeal of e-cigarettes. Aims and Methods In this randomized, double-blind, within-subject crossover study, 20 non-nicotine-naïve participants were switched among three e-liquids (free-base nicotine 20 mg/mL, nicotine salt 20 mg/mL, nicotine salt 40 mg/mL) using a refillable pod system and a standardized vaping protocol (one puff every 30 seconds, 10 puffs total). Serum nicotine concentrations and vital signs were assessed over 180 minutes; direct effects, craving, satisfaction, withdrawal, and respiratory symptoms were measured using questionnaires. CYP2A6 genotypes and the nicotine metabolite ratio were also assessed.

Results

Eleven (55%) participants were male and the median age was 23.5 years (range 18–67). All three formulations differed significantly in peak serum nicotine concentration (baseline adjusted Cmax, median (range): 12.0 ng/mL (1.6–27.3), 5.4 ng/mL (1.9–18.7), and 3.0 ng/mL (1.3–8.8) for nicotine salt 40 mg/mL, nicotine salt 20 mg/mL and free-base 20 mg/mL, respectively). All groups reached Cmax 2.0–2.5 minutes (median) after their last puff. Differences in subjective effects were not statistically significant. No serious adverse events were observed.

Conclusions

Free-base 20 mg/mL formulations achieved lower blood nicotine concentrations than nicotine salt 20 mg/mL, while 40 mg/mL nicotine salt yielded concentrations similar to cigarette smoking. The findings can inform regulatory policy regarding e-liquids and their potential use in smoking cessation.

Implications

Nicotine salt formulations inhaled by an e-cigarette led to higher nicotine delivery compared to nicotine-free-base formulations with the same nicotine concentration. These findings should be considered in future regulatory discussions. The 40 mg/mL nicotine salt formulation showed similar nicotine delivery as combustible cigarettes, albeit at concentrations over the maximum limit for e-liquids allowed in the European Union. Nicotine delivery resembling combustible cigarettes might be beneficial for smokers willing to quit to adequately alleviate withdrawal symptoms. However, increased nicotine delivery can also pose a public health risk, raising concerns about abuse liability, especially among youth and nonsmokers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Over StudiesNicotineElectronic Nicotine Delivery SystemsVapingHumansMaleAdultFemaleYoung AdultDouble-Blind MethodMiddle AgedAdolescentAdministration, InhalationAgedCytochrome P-450 CYP2A6

Substanzen

NicotineCytochrome P-450 CYP2A6CYP2A6 protein, human

Autor:innen und Institutionen

  • Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
  • Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
  • Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: Samuel E Christen, Elias Bekka, Felix Hammann, Vera van der Velpen, Chin B Eap, Neal L Benowitz, Manuel Haschke, Evangelia Liakoni

Förderung

  • Department of Teaching and Research
  • Insel Gruppe AG
  • University Hospital Bern

Zitieren

APA

Christen, S. E., Hermann, L., Bekka, E., Vonwyl, C., Hammann, F., van der Velpen, V., Eap, C. B., Benowitz, N. L., Haschke, M., & Liakoni, E. (2024). Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae074

Vancouver

Christen SE, Hermann L, Bekka E, Vonwyl C, Hammann F, van der Velpen V, et al. Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study. Nicotine and Tobacco Research. 2024. doi:10.1093/ntr/ntae074

BibTeX
@article{Christen2024,
  author = {Christen, Samuel E and Hermann, Laura and Bekka, Elias and Vonwyl, Celina and Hammann, Felix and van der Velpen, Vera and Eap, Chin B and Benowitz, Neal L and Haschke, Manuel and Liakoni, Evangelia},
  title = {Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study},
  journal = {Nicotine and Tobacco Research},
  year = {2024},
  doi = {10.1093/ntr/ntae074}
}
Kostenlos starten →